Unveiling QuestDirect: A Paradigm Shift in Healthcare
In a groundbreaking move, Quest Diagnostics has unveiled QuestDirect, an innovative online platform that empowers individuals to take charge of their health by ordering and paying for lab tests from the comfort of their own homes.
A Comprehensive Suite of Tests for Optimal Health
QuestDirect offers an extensive array of 35 diagnostic test packages, meticulously designed to cater to a wide range of health concerns. From comprehensive general health and wellness panels to specialized tests for men’s and women’s health, heart health, and digestive health, QuestDirect has got you covered.
Seamless Process: From Order to Results
Ordering tests through QuestDirect is a breeze. Simply select the tests you need online, where independent physicians provide clinical oversight and order the testing. Then, schedule an appointment at one of Quest’s conveniently located patient service centers for specimen collection.
Convenient Access through Retail Partnerships
Through strategic collaborations with retail giants Safeway and Walmart, QuestDirect is expanding its reach, making its services available at over 200 patient service centers within retail store locations by the end of the year.
Fast and Accessible Results
QuestDirect delivers results within a week, accessible through a secure online portal. Share your results with your designated doctor or family member for comprehensive health monitoring.
Broad Availability with Exceptions
QuestDirect’s services are currently available in all states except Arizona, Indiana, Oklahoma, Alaska, Hawaii, and Puerto Rico. Please note that QuestDirect cannot bill insurance for tests purchased through its platform, including Medicare and Medicaid. Payment is the patient’s responsibility.
Strategic Acquisitions and Collaborations
Quest Diagnostics has recently completed the acquisition of Oxford Immunotec‘s U.S. laboratory services business, adding the T-SPOT.TB tuberculosis and Accutix tick-borne disease tests to its diagnostics portfolio.
Additionally, Quest and Oxford Immunotec are collaborating on further development of the T-SPOT.TB test in the U.S., while Quest plans to continue offering Qiagen’s QuantiFERON TB services.
